Production of monoclonal antibodies specific to theophylline-treated lymphocytes

Hybridoma. 1987 Aug;6(4):403-11. doi: 10.1089/hyb.1987.6.403.

Abstract

The T11 molecule is reported to play a key role in T lymphocytes activation. Moreover, theophylline is known to modify the functional properties of T lymphocytes probably inducing early changes in T11 molecule during T cell activation. Aim of our work was to clarify the effect on T lymphocyte surface after in vitro treatment with theophylline. In this paper, we describe the production and the functional properties of several monoclonal antibodies obtained by immunizing Balb/c mice with theophylline treated cells. Some of the monoclonal antibodies reacted only with the theophylline-treated lymphocytes and showed a promitogenic activity, enhancing the expression of T activated cell antigen. These monoclonal antibodies seem to demonstrate the existence of a membrane molecule which appears on lymphocytes surface after a trigger signal occurring in the early stages of T cell activation likely related to the T11 dependent alternative pathway.

MeSH terms

  • Animals
  • Antibodies, Monoclonal / biosynthesis*
  • Antibodies, Monoclonal / immunology
  • Antigens, Surface / analysis
  • Humans
  • Interleukin-2 / biosynthesis
  • Lymphocyte Activation / drug effects
  • Male
  • Mice
  • Mice, Inbred BALB C
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology*
  • Theophylline / pharmacology*
  • Tumor Necrosis Factor Receptor Superfamily, Member 7

Substances

  • Antibodies, Monoclonal
  • Antigens, Surface
  • Interleukin-2
  • Tumor Necrosis Factor Receptor Superfamily, Member 7
  • Theophylline